Apoorva Ambavane
Apoorva Ambavane publishes mostly in Economics and Econometrics, Oncology and Pulmonary and Respiratory Medicine, on topics such as Economic and Financial Impacts of Cancer, Health Systems, Economic Evaluations, Quality of Life and Colorectal Cancer Treatments and Studies.
- World rank
- #5,029,693 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #302,457 of 367,258
- Works
- 46
- Citations
- 384
- Citations per work
- 8.3
What does Apoorva Ambavane research?
Apoorva Ambavane's work is mostly in Economics, Econometrics and Finance (38%), Medicine (32%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Social Sciences1838.5%
- Health Sciences1532.0%
- Medicine1532.0%
- Everything else920.5%
- Life Sciences49.0%
- 1Economics and Econometrics38% of their works
- 2Oncology21% of their works
- 3Pulmonary and Respiratory Medicine7% of their works
- 4Molecular Biology6% of their works
- 5Hematology3% of their works
- 6Cancer Research3% of their works
Research topics
Which keywords describe Apoorva Ambavane's research?
The keywords of their largest research topics: Cost of Care, Financial Toxicity, Cost-effectiveness Analysis, Quality of Life, Cetuximab, KRAS Mutations, Drug Development Costs and Generic Drugs.
- Mutational Signatures
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- Renal Cell Carcinoma
- Generic Drugs
- KRAS Mutations
- Quality of Life
- Financial Toxicity
- Cost of Care
- Cost-effectiveness Analysis
- Cetuximab
- Drug Development Costs
- Metastatic
- BRAF gene
- MAP Kinase
- Cancer Genomics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 16 words, with their numbers
- Cost of Care211 topic
- Financial Toxicity211 topic
- Cost-effectiveness Analysis181 topic
- Quality of Life181 topic
- Cetuximab71 topic
- KRAS Mutations71 topic
- Drug Development Costs51 topic
- Generic Drugs51 topic
- Metastatic51 topic
- Renal Cell Carcinoma51 topic
- BRAF gene41 topic
- Immune Checkpoint Blockade41 topic
- MAP Kinase41 topic
- PD-1 and PD-L141 topic
- Cancer Genomics31 topic
- Mutational Signatures31 topic
Where does Apoorva Ambavane work?
Apoorva Ambavane's main affiliation in the publication record is EVRAZ (United Kingdom), United Kingdom.
How many publications and citations does Apoorva Ambavane have?
OpenAlex counts 46 works and 384 citations for Apoorva Ambavane, an h-index of 10, ranking #5,029,693 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Apoorva Ambavane. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.